StockData
Kymera Therapeutics, Inc. logo

Kymera Therapeutics, Inc. (KYMR) stock

KYMRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/30215% above fair value
$115.31−4.08 (-3.42%)

Close on Nov 20, 2026Market cap $9.84BP/E –Yield –

Kymera Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kymera Therapeutics's market cap was $11.16B on Nov 11, 2026, against $4.87B a year earlier. Over the last 5 years it ranged from $646.40M to $11.16B, with a median of $2.18B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$11.16B+100.0%
2025Dec 31, 2025$5.58B+114.3%
2024Dec 31, 2024$2.60B+84.5%
2023Dec 29, 2023$1.41B+3.3%
2022Dec 30, 2022$1.37B-58.0%
2021Dec 31, 2021$3.25B+18.1%
2020Dec 31, 2020$2.76B–

More Kymera Therapeutics figures

See a number that looks wrong?